Immunophenotypic Abnormalities in Acute Myeloid Leukemia Associated with NPM1 Mutation and Clinical Significance of Minimal Residual Disease Detection

被引：0
|
作者：
Zhou, Yi [1 ]
Wu, David [1 ]
Chen, Xueyan [1 ]
Fromm, Jonathan R. [1 ]
Wood, Brent L. [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1531
引用
收藏
页码：387A / 388A
页数：2
相关论文
共 50 条
  • [41] Pattern associated leukemia immunophenotypes and measurable disease detection in acute myeloid leukemia or myelodysplastic syndrome with mutated NPM1
    Zhou, Yi
    Moon, Andres
    Hoyle, Eric
    Fromm, Jonathan R.
    Chen, Xueyan
    Soma, Lori
    Salipante, Stephen J.
    Wood, Brent L.
    Wu, David
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2019, 96 (01) : 67 - 72
  • [42] Monitoring of Minimal Residual Disease in NPM1 Mutated Acute Myeloid Leukemia (AML): Results of the AML Study Group (AMLSG)
    Kroenke, Jan
    Schlenk, Richard
    Jensen, Kai-Ole
    Eiwen, Karina
    Habdank, Marianne
    Spaeth, Daniela
    Krauter, Juergen
    Ganser, Arnold
    Doehner, Hartmut
    Doehner, Konstanze
    BLOOD, 2008, 112 (11) : 260 - 260
  • [43] Assessment of Minimal Residual Disease by NGS in Acute Myeloid Leukemia Patients by Monitoring FLT3 and NPM1 Mutations
    Xie, Z.
    Carson, A. R.
    McClain, V.
    Miller, J. E.
    Levis, M.
    Stenzel, T.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (02): : S10 - S10
  • [44] Leukemia cutis associated with NPM1 mutation
    Huen, A.
    Luskin, M.
    Stewart, C.
    Perl, A.
    Rosenbach, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (07) : 1926 - 1926
  • [45] Novel complex mutation in NPM1 gene in patient with acute myeloid leukemia
    Jeziskova, Ivana
    Semerad, Lukas
    Dvorakova, Dana
    Janeckova, Veronika
    Culen, Martin
    Kunetkova, Tamara
    Mayer, Jiri
    Racil, Zdenek
    LEUKEMIA & LYMPHOMA, 2017, 58 (03) : 746 - 748
  • [46] Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
    Chou, W-C
    Tang, J-L
    Wu, S-J
    Tsay, W.
    Yao, M.
    Huang, S-Y
    Huang, K-C
    Chen, C-Y
    Huang, C-F
    Tien, H-F
    LEUKEMIA, 2007, 21 (05) : 998 - 1004
  • [47] Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations
    W-C Chou
    J-L Tang
    S-J Wu
    W Tsay
    M Yao
    S-Y Huang
    K-C Huang
    C-Y Chen
    C-F Huang
    H-F Tien
    Leukemia, 2007, 21 : 998 - 1004
  • [48] Acute Promyelocytic Leukemia or Acute Myeloid Leukemia with Mutated NPM1?
    Cloobs-Venezia, Maximiliano
    Dejesus, Jimena
    Malusardi, Cecilia
    Auat, Mariangeles
    Altube, Alejandra
    TURKISH JOURNAL OF HEMATOLOGY, 2022, 39 (04) : 262 - 263
  • [49] Molecular measurable residual disease monitoring and transplant indications in NPM1 mutated acute myeloid leukemia
    Christopher, Mary R.
    Nawas, Mariam T.
    Reagan, John L.
    BONE MARROW TRANSPLANTATION, 2025, 60 (02) : 135 - 143
  • [50] A novel quantitative assessment of minimal residual disease in patients with acute myeloid leukemia carrying NPM1 (nucleophosmin) exon 12 mutations
    D Dvorakova
    M Lengerova
    J Pospisilova
    I Palasek
    J Mayer
    Leukemia, 2009, 23 : 793 - 796
12345